Jobs
View more job listings or post a job
Gate Bioscience Director of Toxicology
Nura Bio Director of Toxicology
Nura Bio Vice President of CMC
MilliporeSigma Emerging Biotech Market Development Manager - San Fransisco
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Post a job

Workshop

[In-Person] Therapeutic Antibody Discovery and Development: Hit Generation, Engineering, Characterization, CMC and IND Enabling studies


Speakers: Joshua Park (Loxo at Lilly), Srinivasa Bandi (Nutcracker Therapeutics), Alex Yang (Vir Biotechnology), Wendy Chen (Amgen), Lilia Koriazova (Erasca), Chris Frantz (Seagen), Yue Liu (Ab Studio)
Organizers: Wenfeng Xu, PhD (Chantibody) and Joshua Park, PhD (Loxo at Lilly)
Date: 2024-02-06
Time: 8:40-17:00 Pacific Time
Registration fee: Regular attendees: $295; Academic/Students/Postdocs: $95; Out-of-Pocket: $45; Major Sponsorship: $3000; Vendor Show: $695, Happy Hour Sponsorship: $975; Lunch Sponsorship: $1250; On-site Registration: $500
Location: Crowne Plaza, Foster City, CA (San Francisco Bay Area)
Major Sponsor: (2)Abzena; WuXi Biologics
Vendor show vendors registered to date: (18).; Altruist Biologics; Alturas Analytics; Aton Biotech; ATUM; BioTether Sciences; Correlia Biosystems Inc; Curia; Ellegaard BioResearch; Emery Pharma; IDEXX BioAnalytics; ITR Laboratories; JOINN Biologics Us Inc.; Meadowhawk Biolabs; OmniAb; Pace Life Sciences; Protein Metrics; Waters
Registration: http://www.PBSS.org
Registration deadline:2024-02-03  (it will close sooner if the seating cap is reached)

About the Topic

Sponsored by Abzena, WuXi Biologics, Mycenax, Alturas Analytics

Agenda: 
Time (PST)  Topic Presenter
8:45-9:00 am  PBSS Welcome and Introduction  Shichang Miao, PBSS 
9:00-9:30 am  Overview of Therapeutic Antibodies Joshua Park, PhD, Executive Director, Antibody Discovery, Loxo Oncology at Lilly
9:30-10:30 am  Antibody Discovery  Joshua Park, PhD, Executive Director, Antibody Discovery, Loxo Oncology at Lilly
10:30-10:40 am Major Sponsor Presentation Abzena
10:40-11:00 am  Break and Vendor Show  -
11:00am-12:00 pm Antibody Engineering Srinivasa Bandi, Associate Director, Nutcracker Therapeutics
12:00-12:50 pm  Lunch  Sponsored by Mycenax
12:50-1:50 pm  In Vitro Assays and Characterization for Antibody Discovery and Development  Alex Yang, PhD, Senior Scientist, Vir Biotechnology
1:50-2:50 pm  In Vivo Models for Antibody Discovery and Clinical Efficacy Wendy Chen, PhD, Scientist, Amgen
2:50-3:00 pm  Major Sponsor Presentation WuXi Biologics
3:00-3:20 pm  Break and Vendor Show 
3:20-4:05 pm  Cell Line Development and CMC  Lilia Koriazova, PhD, Sr. Director, Biologics Pharmaceutical Sciences, Erasca
4:05-4:35 pm  IND Enabling Tox Studies Chris Frantz, PhD, Director, Toxicology, Seagen 
4:35-5:10 pm  AI for Antibody Discovery Yue Liu, PhD, Founder and CEO, Ab Studio Inc.
5:10-5:40 pm  Panel Discussion All speakers
5:40-6:40 pm Happy Hour Sponsored by Alturas Analytics
 


2025-02-13, [Free Online] The Science and Stories of Promising Biotech Startups
2025-02-26, [In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
2025-04-01, [For vendors ONLY] Seattle PBSS Seminar Luncheon Vendor Show
2025-04-09, [In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)
2025-04-22, [Free Online Workshop] Career Transitions for Research Scientists: BD/Sales in CROs, CDMOs, and Lab Products & Instruments
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
2025-05-05, [Free Online] Highlights of 2024 FDA Drug Approvals
2025-05-12, [In-Person] Preclinical Pharmacology Studies and Translational Medicine for Drug Discovery and Development
2025-06-02, [In-Person] Metabolism and Transport-mediated Drug-Drug Interaction: Current Practices, Regulatory Guidances, and Their Impact on Drug Development
©Pharmaceutical & BioScience Society, International; Last Modified: 2/12/2025; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Allucent Experts bringing development innovation w/ClinPharm Modeling & Simulation deliverables to inform dose, study design, modeling+development strategies.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad